202 related articles for article (PubMed ID: 28072618)
1. 18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
Park MJ; Oh JS; Roh JL; Kim JS; Lee JH; Nam SY; Kim SY
Clin Nucl Med; 2017 Mar; 42(3):e149-e156. PubMed ID: 28072618
[TBL] [Abstract][Full Text] [Related]
2. Detection of distant metastasis and prognostic prediction of recurrent salivary gland carcinomas using
Lee SH; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Oral Dis; 2018 Sep; 24(6):940-947. PubMed ID: 29688610
[TBL] [Abstract][Full Text] [Related]
3. Prediction of distant metastasis and survival in adenoid cystic carcinoma using quantitative
Lim WS; Oh JS; Roh JL; Kim JS; Kim SJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Feb; 77():98-104. PubMed ID: 29362133
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment metabolic tumor volume predicts tumor metastasis and progression in high-grade salivary gland carcinoma.
Almuhaimid TM; Lim WS; Roh JL; Oh JS; Kim JS; Kim SJ; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2485-2493. PubMed ID: 30293119
[TBL] [Abstract][Full Text] [Related]
6. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
Sharma P; Jain TK; Singh H; Suman SK; Faizi NA; Kumar R; Bal C; Malhotra A; Kumar R
Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glands.
Kim JY; Lee SW; Kim JS; Kim SY; Nam SY; Choi SH; Roh JL; Choi EK; Kim JH; Song SY; Yoon SM; Kim YS; Kim SS; Park JH; Shin HS; Chang SK; Ahn SD
J Nucl Med; 2012 Jun; 53(6):881-6. PubMed ID: 22573820
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.
Roh JL; Ryu CH; Choi SH; Kim JS; Lee JH; Cho KJ; Nam SY; Kim SY
J Nucl Med; 2007 Feb; 48(2):240-6. PubMed ID: 17268021
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology.
Cheng NM; Hsieh CE; Liao CT; Ng SH; Wang HM; Fang YD; Chou WC; Lin CY; Yen TC
Clin Nucl Med; 2019 May; 44(5):351-358. PubMed ID: 30932974
[TBL] [Abstract][Full Text] [Related]
12. Up-front F18-FDG PET/CT in suspected salivary gland carcinoma.
Westergaard-Nielsen M; Rohde M; Godballe C; Eriksen JG; Larsen SR; Gerke O; Nguyen N; Nielsen MK; Nielsen AL; Thomassen A; Asmussen JT; Diaz A; Høilund-Carlsen PF; Bjørndal K
Ann Nucl Med; 2019 Aug; 33(8):554-563. PubMed ID: 31102059
[TBL] [Abstract][Full Text] [Related]
13. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
Kim MJ; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2013 Mar; 20(3):899-905. PubMed ID: 23161114
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
[TBL] [Abstract][Full Text] [Related]
15. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment Primary Tumor and Nodal SUVmax Values on 18F-FDG PET/CT Images Predict Prognosis in Patients With Salivary Gland Carcinoma.
Hsieh CE; Cheng NM; Chou WC; Venkatesulu BP; Chou YC; Liao CT; Yen TC; Lin CY
Clin Nucl Med; 2018 Dec; 43(12):869-879. PubMed ID: 30273205
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Utility of
Nakajima R; Patel SG; Katabi N; Flukes S; Mauguen A; Ganly I; Schöder H
AJR Am J Roentgenol; 2021 May; 216(5):1344-1356. PubMed ID: 33826358
[No Abstract] [Full Text] [Related]
18. Pretreatment Primary Tumor SUVmax on 18F-FDG PET/CT Images Predicts Outcomes in Patients With Salivary Gland Carcinoma Treated With Definitive Intensity-Modulated Radiation Therapy.
Hsieh CE; Ho KC; Hsieh CH; Yen TC; Liao CT; Wang HM; Lin CY
Clin Nucl Med; 2017 Sep; 42(9):655-662. PubMed ID: 28650891
[TBL] [Abstract][Full Text] [Related]
19. Benefits of
Wen G; Gu J; Zhou W; Wang L; Tian Y; Dong Y; Fu L; Wu H
Eur Radiol; 2020 Sep; 30(9):5089-5098. PubMed ID: 32346795
[TBL] [Abstract][Full Text] [Related]
20. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
